1. Home
  2. Webinar Quiz: The Pharmacogenomics of Targeted Therapy-ISH and Breast Cancer

Webinar Quiz: The Pharmacogenomics of Targeted Therapy-ISH and Breast Cancer

"(Required)" indicates required fields

This field is for validation purposes and should be left unchanged.
The Pharmacogenomics of Targeted Therapy-ISH and Breast Cancer(Required)
2. The two main epithelial components of the mammary glands are the ducts and the:(Required)
3. Most invasive carcinomas of the breast arise from these epithelial cells:(Required)
4. Which of the following histological manifestations is seen with invasive carcinoma of the breast, and not seen with in situ carcinomas?(Required)
5. Which of the following statements regarding cancer staging is FALSE?(Required)
6. Progesterone receptor staining is required in addition to estrogen receptor to screen for:(Required)
7. The Allred scoring system for ER/PR looks at:(Required)
8. Her-2 staining elicits a reflex test of ISH when the staining is:(Required)
9. Which of the following is consistent with the “Basal-like” subtype of breast cancer?(Required)
10. Metastatic breast cancers often go to the lung, skin, brain, or bone. Which of the following markers can be used to confirm the carcinoma is from the breast?(Required)